Allergan Korea launches new treatment for hypotrichosis of the eyelashes

Published: 2009-11-26 06:57:00
Updated: 2009-11-26 06:57:00
Allergan Korea said it has launched LATISSEā„¢ (bimatoprost ophthalmic solution) 0.03% as a novel treatment for hypotrichosis of the eyelashes.

Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes.

LATISSE is the first and only science-based treatment approved ...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.